Crosstalk between noncoding RNAs and ferroptosis: new dawn for overcoming cancer progression

Xuefei Zhang1, Lingling Wang1, Haixia Li1

  • 1Department of Ultrasonography, Harbin Medical University Cancer Hospital, 150 Haping Road, 150040, Harbin, China.

Cell Death & Disease
|July 26, 2020
PubMed

Insights

Ferroptosis, a novel cell death pathway, offers a new avenue for cancer therapy by eliminating cancer cells independently of apoptosis. This review summarizes ferroptosis-associated noncoding RNAs and their therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Mechanisms

Background:

  • Cancer progression is hindered by apoptosis resistance in cancer cells.
  • Ferroptosis, a distinct programmed cell death, involves lipid peroxidation and eliminates cancer cells independently of apoptosis.
  • Understanding ferroptosis regulation is crucial for developing novel cancer therapies.

Purpose of the Study:

  • To review the roles of noncoding RNAs (ncRNAs) in ferroptosis.
  • To summarize the functions of ferroptosis-associated ncRNAs across various cancer types.
  • To propose future research directions and therapeutic strategies targeting ncRNAs in ferroptosis.

Main Methods:

  • Literature review of studies on noncoding RNAs and ferroptosis in cancer.
  • Analysis of identified ferroptosis-associated ncRNAs and their regulatory mechanisms.
  • Discussion of therapeutic implications and future research avenues.

Main Results:

  • Noncoding RNAs play significant roles in regulating ferroptosis in cancer cells.
  • Specific ncRNAs have been identified that modulate ferroptosis, impacting cancer progression.
  • Existing research provides a partial understanding of ncRNA-mediated ferroptosis regulation.

Conclusions:

  • Ferroptosis-associated ncRNAs represent promising therapeutic targets for overcoming cancer progression.
  • Further research is needed to fully elucidate the mechanisms and therapeutic potential of ncRNAs in ferroptosis.
  • Targeting ncRNAs involved in ferroptosis could lead to innovative cancer treatment strategies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.7K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K